abstract |
Y4 receptor agonists which are selective of the Y4 receptor over the Y1 and Y2 receptors, are useful in the prevention and/or treatment of damage to bowel function caused by radiation therapy, radiation exposure, cytotoxic chemotherapy, inflammation or ischemia-reperfusion of intestinal mucosa. |